β-Catenin promoter chip-chip reveals potential schizophrenia and bipolar disorder gene network

Journal of Neurogenetics

Volumn 24, Issue 4, 2010, Pages 182-193

  Pedrosa, Erika ^a   Shah, Abhishek ^a   Tenore, Christopher ^a   Capogna, Michael ^a   Villa, Catalina ^a   Guo, Xingyi ^a   Zheng, Deyou ^a   Lachman, Herbert M ^a  

^a ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

Author keywords

bipolar disorder; Chip; chromatin; GSK3 ; lithium schizophrenia

Indexed keywords

BETA CATENIN; DAXX PROTEIN; GLYCOGEN SYNTHASE KINASE 3BETA; LITHIUM SALT; PROTEIN MDM2;

ARTICLE; AUTISM; BIPOLAR DISORDER; CHROMATIN IMMUNOPRECIPITATION; CONTROLLED STUDY; COPY NUMBER VARIATION; GENE EXPRESSION PROFILING; GENE REGULATORY NETWORK; GENETIC ASSOCIATION; HUMAN; HUMAN CELL; HUMAN TISSUE; MICROARRAY ANALYSIS; NERVE CELL PLASTICITY; NONHUMAN; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROMOTER REGION; SCHIZOPHRENIA; SIGNAL TRANSDUCTION; SINGLE NUCLEOTIDE POLYMORPHISM;

BETA CATENIN; BIPOLAR DISORDER; BRAIN; CADHERINS; CALCIUM CHANNELS, N-TYPE; CHILD; CHILD DEVELOPMENT DISORDERS, PERVASIVE; CHROMATIN IMMUNOPRECIPITATION; FEMALE; FETUS; GENE REGULATORY NETWORKS; GENOME-WIDE ASSOCIATION STUDY; GLYCOGEN SYNTHASE KINASE 3; HUMANS; INOSITOL PHOSPHATES; LITHIUM; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; PROMOTER REGIONS, GENETIC; QB-SNARE PROTEINS; QC-SNARE PROTEINS; RECEPTOR, FIBROBLAST GROWTH FACTOR, TYPE 1; SCHIZOPHRENIA; SIGNAL TRANSDUCTION; TRANSCRIPTIONAL ACTIVATION;

EID: 78649351382     PISSN: 01677063     EISSN: 15635260     Source Type: Journal    
DOI: 10.3109/01677063.2010.495182     Document Type: Article

References (94)

1. Adegbola, A., Gao, H., Sommer, S., & Browning, M. (2008). A novel mutation in JARID1C/SMCX in a patient with autism spectrum disorder (ASD). Am J Med Genet A, 146A, 505-511.
2. Arai, S., Shibata, H., Sakai, M., Ninomiya, H., Iwata, N., Ozaki, N., & Fukumaki, Y. (2009). Association analysis of the glutamic acid decarboxylase 2 and the glutamine synthetase genes (GAD2, GLUL) with schizophrenia. Psychiatr. Genet, 19, 6-13.
3. Baum, A. E., Akula, N., Cabanero, M., Cardona, I., Corona, W., Klemens, B., Schulze, T. G., Cichon, S., Rietschel, M., Nothen, M. M., et al. (2008). A genome-wide association study implicates diacylglycerol kinase eta (DGKH) and several other genes in the etiology of bipolar disorder. Mol. Psychiatry, 13, 197-207.
4. Benedetti, F., Serretti, A., Pontiggia, A., Bernasconi, A., Lorenzi, C., Colombo, C., & Smeraldi, E. (2005). Long-term response to lithium salts in bipolar illness is infl uenced by the glycogen synthase kinase 3-beta-50 T/C SNP. Neurosci. Lett, 376, 51-55.
5. Benes, F. M., Lim, B., Matzilevich, D., Subburaju, S., & Walsh, J. P. (2008) Circuitry-based gene expression profi les in GABA cells of the trisynaptic pathway in schizophrenics versus bipolars. Proc Natl Acad Sci USA, 105, 20935-20940.
6. Berridge, M. J., & Irvine, R. F. (1989). Inositol phosphates and cell signalling. Nature, 341, 197-205.
7. Berry, G. T., Buccafusca, R., Greer, J. J., & Eccleston, E. (2004). Phosphoinositide defi ciency due to inositol depletion is not a mechanism of lithium action in brain. Mol. Genet. Metab, 82, 87-92.
8. Bertrand, N., & Dahmane, N. (2006). Sonic hedgehog signaling in forebrain development and its interactions with pathways that modify its effects. Trends Cell Biol, 16, 597-605.
9. Bodai, L., Pardi, N., Ujfaludi, Z., Bereczki, O., Komonyi, O., Balint, E., & Boros, I. M. (2007). Daxx-like protein of Drosophila interacts with Dmp53 and affects longevity and ark mRNA level. J. Biol. Chem, 282, 36386-36393.
10. Bosetti, F., Seemann, R., Bell, J. M., Zahorchak, R., Friedman, E., Rapoport, S. I., & Manickam, P. (2002). Analysis of gene expression with cDNA microarrays in rat brain after 7 and 42 days of oral lithium administration. Brain Res. Bull, 57, 205-209.
11. Brandish, P. E., Su, M., Holder, D. J., Hodor, P., Szumiloski, J., Kleinhanz, R. R., Forbes, J. E., McWhorter, M. E., Duenwald, S. J., Parrish, M. L. et al. (2005). Regulation of gene expression by lithium and depletion of inositol in slices of adult rat cortex. Neuron, 45, 861-872.
12. Bryceson, Y. T., Foster, J. A., Kuppusamy, S. P., Herkenham, M., & Long, E. O. (2005). Expression of a killer cell receptor-like gene in plastic regions of the central nervous system. J. Neuroimmunol, 161, 177-182.
13. Bucan, M., Abrahams, B.S., Wang, K., Glessner, J.T., Herman, E.I., Sonnenblick, L.I., Alvarez Retuerto, A.I., Imielinski, M., Hadley, D., Bradfi eld, J.P., Kim, C., Gidaya, N.B., Lindquist, I., Hutman, T., Sigman, M., Kustanovich, V., Lajonchere, C.M., Singleton, A., Kim, J., Wassink, T.H., McMahon, W.M., Owley, T., Sweeney, J.A., Coon, H., Nurnberger, J.I., Li, M., Cantor, R.M., Minshew, N.J., Sutcliffe, J.S., Cook, E.H., Dawson, G., Buxbaum, J.D., Grant, S.F., Schellenberg, G.D., Geschwind, D.H., Hakonarson, H. PLoS Genet. (2009). Genome-wide analyses of exonic copy number variants in a family-based study point to novel autism susceptibility genes. PLoS Genet, 5, e1000536. Epub 2009 Jun 26.
14. Citrome, L. (2009). Adjunctive lithium and anticonvu lsants for the treatment of schizophrenia: What is the evidence? Expert Rev. Neurother, 9, 55-71.
15. Divish, M. M., Sheftel, G., Boyle, A., Kalasapudi, V. D., Papolos, D. F., & Lachman, H. M. (1991). Differential effect of lithium on fos protooncogene expression mediated by receptor and postreceptor activators of protein kinase C and cyclic adenosine monophosphate: Model for its antimanic action. J. Neurosci. Res, 28, 40-48.
16. Freyberg, Z., Ferrando, S. J., & Javitch, J. A. (2010). Roles of the Akt/GSK-3 and Wnt signaling pathways in schizophrenia and antipsychotic drug action. Am J Psychiatry, 167, 388-396.
17. Fukuchi, M., Nii, T., Ishimaru, N., Minamino, A., Hara, D., Takasaki, I., Tabuchi, A., & Tsuda, M. (2009). Valproic acid induces up-or down-regulation of gene expression responsible for the neuronal excitation and inhibition in rat cortical neurons through its epigenetic actions. Neurosci. Res, 65, 35-43.
18. Gaspar, P. A., Bustamante, M. L., Silva, H., & Aboitiz, F. (2009). Molecular mechanisms underlying glutamatergic dysfunction in schizophrenia: Therapeutic implications. J Neurochem, 111, 891-900.
19. Glessner, J. T., Wang, K., Cai, G., Korvatska, O., Kim, C. E., Wood, S., Zhang, H., Estes, A., Brune, C. W., Bradfi eld, J. P., et al. (2009). Autism genome-wide copy number variation reveals ubiquitin and neuronal genes. Nature, 459, 569-573.
20. Gothelf, D., Schaer, M., & Eliez, S. (2008). Genes, brain development and psychiatric phenotypes in velo-cardio-facial syndrome. Dev. Disabil. Res. Rev, 14, 59-68.
21. Gould, T. D., Picchini, A. M., Einat, H., & Manji, H. K. (2006). Targeting glycogen synthase kinase-3 in the CNS: Implications for the development of new treatments for mood disorders. Curr. Drug Targets, 7, 1399-1409.
22. Grimes, C.A., Jope, R.S. (2001). The multifaceted roles of glycogen synthase kinase 3beta in cellular signaling. Prog Neurobiol, 65, 391-426.
23. Gross, I., Armant, O., Benosman, S., de Aguilar, J. L., Freund, J. N., Kedinger, M., Licht, J. D., Gaiddon, C., & Loeffl er, J. P. (2007). Sprouty2 inhibits BDNF-induced signaling and modulates neuronal differentiation and survival. Cell Death Differ, 14, 1802-1812.
24. Harris, L. W., Lockstone, H. E., Khaitovich, P., Weickert, C. S., Webster, M. J., & Bahn, S. (2009). Gene expression in the prefrontal cortex during adolescence: Implications for the onset of schizophrenia. BMC Med. Genomics, 2, 28.
25. Hawasli, A. H., Benavides, D. R., Nguyen, C., Kansy, J. W., Hayashi, K., Chambon, P., Greengard, P., Powell, C. M., Cooper, D. C., & Bibb, J. A. (2007). Cyclin-dependent kinase 5 governs learning and synaptic plasticity via control of NMDAR degradation. Nat. Neurosci, 10, 880-886.
26. Hennah, W., Tuulio-Henriksson, A., Paunio, T., Ekelund, J., Varilo, T., Partonen, T., Cannon, T. D., Lonnqvist, J., & Peltonen, L. (2005). A haplotype within the DISC1 gene is associated with visual memory functions in families with a high density of schizophrenia. Mol. Psychiatry, 10, 1097-1103.
27. Hollister, L. E., & Trevino, E. S. (1999). Calcium channel blockers in psychiatric disorders: A review of the literature. Can. J. Psychiatry, 44, 658-664.
28. Huang, Y. S., & Shih, H. M. (2009). Daxx positively modulates beta-catenin/TCF4-mediated transcriptional potential. Biochem. Biophys. Res. Commun, 386, 762-768.
29. International Schizophrenia Consortium, Purcell, S. M., Wray, N. R., Stone, J. L., Visscher, P. M., O'Donovan, M. C., Sullivan, P. F., & Sklar, P. (2009). Common poly-genic variation contributes to risk of schizophrenia and bipolar disorder. Nature, 460, 748-752.
30. Iwase, S., Lan, F., Bayliss, P., de la Torre-Ubieta, L., Huarte, M., Qi, H. H., Whetstine, J. R., Bonni, A., Roberts, T. M., & Shi, Y. (2007). The X-linked mental retardation gene SMCX/JARID1C defi nes a family of histone H3 lysine 4 demethylases. Cell, 128, 1077-1088.
31. Javitt, D. C. (2009). Glycine transport inhibitors for the treatment of schizophrenia: Symptom and disease modifi cation. Curr Opin Drug Discov Devel, 12, 468-478.
32. Jope, R. S., Song, L., Li, P. P., Young, L. T., Kish, S. J., Pacheco, M. A., & Warsh, J. J. (1996). The phosphoinositide signal transduction system is impaired in bipolar affective disorder brain. J. Neurochem, 66, 2402-2409
33. Kalasapudi, V. D., Sheftel, G., Divish, M. M., Papolos, D. F., & Lachman, H. M. (1990). Lithium augments fos protoonocogene expression in PC12 pheochromocytoma cells: Implications for therapeutic action of lithium. Brain Res, 521, 47-54.
34. Karoutzou, G., Emrich, H. M., & Dietrich, D. E. (2008). The myelin-pathogenesis puzzle in schizophrenia: A literature review. Mol Psychiatry, 13, 245-260.
35. Kato, T. (2007). Molecular genetics of bipolar disorder and depression. Psychiatry Clin. Neurosci, 61, 3-19.
36. Katoh, Y., & Katoh, M. (2006). FGF signaling inhibitor, SPRY4, is evolutionarily conserved target of WNT signaling pathway in progenitor cells. Int. J. Mol. Med, 17, 529-532.
37. Kilpinen, H., Ylisaukko-Oja, T., Hennah, W., Palo, O. M., Varilo, T., Vanhala, R., Nieminen-von Wendt, T., von Wendt, L., Paunio, T., & Peltonen, L. (2008). Association of DISC1 with autism and asperger syndrome. Mol. Psychiatry, 13, 187-196.
38. Kim, H. G., Kishikawa, S., Higgins, A. W., Seong, I. S., Donovan, D. J., Shen, Y., Lally, E., Weiss, L. A., Najm, J., Kutsche, K., et al. (2008). Disruption of neurexin 1 associated with autism spectrum disorder. Am. J. Hum. Genet, 82, 199-207.
39. Kim, H. J., & Thayer, S. A. (2009). Lithium increases synapse formation between hippocampal neurons by depleting phosphoinositides. Mol Pharmacol, 75, 1021-1030.
40. Kirov, G., Gumus, D., Chen, W., Norton, N., Georgieva, L., Sari, M., O'Donovan, M.C., Erdogan, F., Owen, M.J., Ropers, H.H., Ullmann, R. (2008). Comparative genome hybridization suggests a role for NRXN1 and APBA2 in schizophrenia. Hum. Mol. Genet, 17, 458-465.
41. Konneker, T., Barnes, T., Furberg, H., Losh, M., Bulik, C. M., & Sullivan, P. F. (2008). A searchable database of genetic evidence for psychiatric disorders. Am. J. Med. Genet. B. Neuropsychiatr. Genet, 147B, 671-675.
42. Kripke, D. F., Nievergelt, C. M., Joo, E., Shekhtman, T., & Kelsoe, J. R. (2009). Circadian polymorphisms associated with affective disorders. J. Circadian Rhythms, 7, 2.
43. Lachman, H. M., Pedrosa, E., Petruolo, O. A., Cockerham, M., Papolos, A., Novak, T., Papolos, D. F., & Stopkova, P. (2007). Increase in GSK3beta gene copy number variation in bipolar disorder. Am. J. Med. Genet. B. Neuropsychiatr. Genet, 144, 259-265.
44. Lai, S. L., Chien, A. J., & Moon, R. T. (2009). Wnt/Fz signaling and the cytoskeleton: Potential roles in tumori-genesis. Cell Res, 19, 532-545.
45. Leucht, S., Kissling, W., & McGrath, J. (2007). Lithium for schizophrenia. Cochrane Database Syst Rev,(3), CD003834.
46. Levy, N. A., & Janicak, P. G. (2000). Calcium channel antagonists for the treatment of bipolar disorder. Bipolar Disord, 2, 108-119.
47. Manji, H. K., & Lenox, R. H. (2000). The nature of bipolar disorder. J Clin Psychiatry, 61(Suppl 13), 42-57.
48. Manji, H. K., Moore, G. J., & Chen, G. (2001). Bipolar disorder: Leads from the molecular and cellular mecha nisms of action of mood stabilizers. B r. J. Psychiatry Suppl, 41, s107-s119.
49. Mao, Y., Ge, X., Frank, C. L., Madison, J. M., Koehler, A. N., Doud, M. K., Tassa, C., Berry, E. M., Soda, T., Singh, K. K., et al. (2009). Disrupted in schizophrenia 1 regulates neuronal progenitor proliferation via modulation of GSK3beta/beta-catenin signaling. Cell, 136, 1017-1031.
50. Marshall, C. R., Noor, A., Vincent, J. B., Lionel, A. C., Feuk, L., Skaug, J., Shago, M., Moessner, R., Pinto, D., Ren, Y., et al. (2008). Structural variation of chromosomes in autism spectrum disorder. Am. J. Hum. Genet, 82, 477-488.
51. Martins-de-Souza, D. (2010) Proteome and transcriptome analysis suggests oligodendrocyte dysfunction in schizophrenia. J Psychiatr Res, 44, 149-156.
52. Maycox, P. R., Kelly, F., Taylor, A., Bates, S., Reid, J., Logendra, R., Barnes, M. R., Larminie, C., Jones, N., Lennon, M., et al. (2009). Analysis of gene expression in two large schizophrenia cohorts identifi es multiple changes associated with nerve terminal function. Mol. Psychiatry 14, 1083-1094.
53. McDonald, S. A., Preston, S. L., Lovell, M. J., Wright, N. A., & Jankowski, J. A. (2006). Mechanisms of disease: From stem cells to colorectal cancer. Nat. Clin. Pract. Gastroenterol. Hepatol, 3, 267-274.
54. McQuillin, A., Rizig, M., & Gurling, H. M. (2007). A microarray gene expression study of the molecular pharmacology of lithium carbonate on mouse brain mRNA to understand the neurobiology of mood stabilization and treatment of bipolar affective disorder. Pharmacogenet Genomics, 17, 605-617.
55. Millar, J. K., Pickard, B. S., Mackie, S., James, R., Christie, S., Buchanan, S. R., Malloy, M. P., Chubb, J. E., Huston, E., Baillie, G. S., et al. (2005). DISC1 and PDE4B are interacting genetic factors in schizophrenia that regulate cAMP signaling. Science, 310, 1187-1191.
56. Ming, G. L., & Song, H. (2009). DISC1 partners with GSK3beta in neurogenesis. Cell, 136, 990-992.
57. Mosimann, C., Hausmann, G., & Basler, K. (2006). Parafi bromin/Hyrax activates Wnt/Wg target gene trans cription by direct association with beta-catenin/Armadillo. Cell, 125, 327-341.
58. Moskvina, V., Craddock, N., Holmans, P., Nikolov, I., Pahwa, J. S., Green, E., Wellcome Trust Case Control Consortium3, Owen, M. J., & O'Donovan, M. C. (2008). Gene-wide analyses of genome-wide association data sets: Evidence for multiple common risk alleles for schizophrenia and bipolar disorder and for overlap in genetic risk. Mol. Psychiatry 14, 252-260.
59. Murphy, K. C. (2002). Schizophrenia and velo-cardio-facial syndrome. Lancet 359, 426-430.
60. Murphy, K. C., & Owen, M. J. (2001). Velo-cardio-facial syndrome: A model for understanding the genetics and pathogenesis of schizophrenia. B r. J. Psychiatry 179, 397-402.
61. Numata, S., Ueno, S. I., Iga, J. I., Song, H., Nakataki, M., Tayoshi, S., Sumitani, S., Tomotake, M., Itakura, M., Sano, A., et al. (2008). Positive association of the PDE4B (phosphodiesterase 4B) gene with schizophrenia in the japanese population. J. Psychiatr. Res.
62. Oberley, M. J., Tsao, J., Yau, P., & Farnham, P. J. (2004). High-throughput screening of chromatin immunopreci-pitates using CpG-island microarrays. Methods Enzymol. 376, 315-334.
63. O'Brien, W. T., Harper, A. D., Jove, F., Woodgett, J. R., Maretto, S., Piccolo, S., & Klein, P. S. (2004). Glycogen synthase kinase-3beta haploinsuffi ciency mimics the behavioral and molecular effects of lithium. J. Neurosci. 24, 6791-6798.
64. O'Donovan, M. C., Craddock, N., Norton, N., Williams, H., Peirce, T., Moskvina, V., Nikolov, I., Hamshere, M., Carroll, L., Georgieva, L., et al. (2008). Identifi cation of loci associated with schizophrenia by genome-wide association and follow-up. Nat. Genet. 40, 1053-1055.
65. O'Donovan, M. C., Craddock, N. J., & Owen, M. J. (2009a). Genetics of psychosis; insights from views across the genome. Hum. Genet. 126, 3-12.
66. O'Donovan, M. C., Norton, N., Williams, H., Peirce, T., Moskvina, V., Nikolov, I., Hamshere, M., Carroll, L., Georgieva, L., Dwyer, S., et al. (2009b). Analysis of 10 independent samples provides evidence for association between schizophrenia and a SNP fl anking fi broblast growth factor receptor 2. Mol. Psychiatry 14, 30-36.
67. Paylor, R., Glaser, B., Mupo, A., Ataliotis, P., Spencer, C., Sobotka, A., Sparks, C., Choi, C. H., Oghalai, J., Curran, S., et al. (2006). Tbx1 haploinsuffi ciency is linked to beha vioral disorders in mice and humans: Implications for 22q11 deletion syndrome. Proc. Natl. Acad. Sci. U. S. A. 103, 7729-7734.
68. Prickaerts, J., Moechars, D., Cryns, K., Lenaerts, I., van Craenendonck, H., Goris, I., Daneels, G., Bouwknecht, J. A., & Steckler, T. (2006). Transgenic mice overexpress-ing glycogen synthase kinase 3beta: A putative model of hyperactivity and mania. J. Neurosci. 26, 9022-9029.
69. Psychiatric GWAS Consortium Coordinating Committee, Cichon, S., Craddock, N., Daly, M., Faraone, S. V., Gejman, P. V., Kelsoe, J., Lehner, T., Levinson, D. F., Moran, A., et al. (2009). Genomewide association studies: History, rationale, and prospects for psychiatric disorders. Am. J. Psychiatry 166, 540-556.
70. Reya, T., & Clevers, H. (2005). Wnt signalling in stem cells and cancer. Nature 434, 843-850. (Pubitemid 40558990)
71. Schwarz, C., Volz, A., Li, C., & Leucht, S. (2008). Valproate for schizophrenia. Cochrane Database Syst Rev,(3), CD004028.
72. Secombe, J., & Eisenman, R. N. (2007). The function and regulation of the JARID1 family of histone H3 lysine 4 demethylases: The myc connection. Cell Cycle, 6, 1324-1328.
73. Seelan, R. S., Khalyfa, A., Lakshmanan, J., Casanova, M. F., & Parthasarathy, R. N. (2008). Deciphering the lithium transcriptome: Microarray profi ling of lithium-modulated gene expression in human neuronal cells. Neuroscience 151, 1184-1197.
74. Serretti, A., Benedetti, F., Mandelli, L., Calati, R., Caneva, B., Lorenzi, C., Fontana, V., Colombo, C., & Smeraldi, E. (2008). Association between GSK-3beta-50T/C polymorphism and personality and psychotic symptoms in mood disorders. Psychiatry Res. 158, 132-140.
75. Serretti, A., Drago, A., & De Ronchi, D. (2009). Lithium pharmacodynamics and pharmacogenetics: Focus on inositol mono phosphatase (IMPase), inositol poliphos-phatase (IPPase) and glycogen sinthase kinase 3 beta (GSK-3 beta). Curr. Med. Chem. 16, 1917-1948.
76. Sillitoe, R. V., & Vogel, M. W. (2008). Desire, disease, and the origins of the dopaminergic system. Schizophr. Bull. 34, 212-219.
77. Sjostrom, S. K., Finn, G., Hahn, W. C., Rowitch, D. H., & Kenney, A. M. (2005). The Cdk1 complex plays a prime role in regulating N-myc phosphorylation and turnover in neural precursors. Dev Cell. 9, 327-338.
78. Sklar, P., Smoller, J. W., Fan, J., Ferreira, M. A., Perlis, R. H., Chambert, K., Nimgaonkar, V. L., McQueen, M. B., Faraone, S. V., Kirby, A., et al. (2008). Whole-genome association study of bipolar disorder. Mol. Psychiatry 13 558-569.
79. St Clair, D., Blackwood, D., Muir, W., Carothers, A., Walker, M., Spowart, G., Gosden, C., & Evans, H. J. (1990). Association within a family of a balanced autosomal translocation with major mental illness. Lancet 336, 13-16.
80. Stark, K. L., Xu, B., Bagchi, A., Lai, W. S., Liu, H., Hsu, R., Wan, X., Pavlidis, P., Mills, A. A., Karayiorgou, M., et al. (2008). Altered brain microRNA biogenesis contributes to phenotypic defi cits in a 22q11-deletion mouse model. Nat. Genet. 40, 751-760.
81. Stefansson, H., Ophoff, R. A., Steinberg, S., Andreassen, O. A., Cichon, S., Rujescu, D., Werge, T., Pietilainen, O. P., Mors, O., Mortensen, P. B., et al. (2009). Common variants conferring risk of schizophrenia. Nature 460, 744-747.
82. Stefansson, H., Rujescu, D., Cichon, S., Pietilainen, O. P., Ingason, A., Steinberg, S., Fossdal, R., Sigurdsson, E., Sigmundsson, T., Buizer-Voskamp, J. E., et al. (2008). Large recurrent microdeletions associated with schizophrenia. Nature 455, 232-236.
83. Szczepankiewicz, A., Skibinska, M., Hauser, J., Slopien, A., Leszczynska-Rodziewicz, A., Kapelski, P., Dmitrzak-Weglarz, M., Czerski, P. M., & Rybakowski, J. K. (2006). Association analysis of the GSK-3beta T-50C gene polymorphism with schizophrenia and bipolar disorder. Neuropsychobiology 53, 51-56. (Pubitemid 43254178)
84. Tabares-Seisdedos, R., Mata, I., Escamez, T., Vieta, E., Lopez-Ilundain, J. M., Salazar, J., Selva, G., Balanza, V., Rubio, C., Martinez-Aran, A., et al. (2008). Evidence for association between structural variants in lissence phaly-related genes and executive defi cits in schizophrenia or bipolar patients from a spanish isolate population. Psychiatr. Genet. 18, 313-317.
85. Terwisscha van Scheltinga, A. F., Bakker, S. C., & Kahn, R. S. (2009). Fibroblast growth factors in schizophrenia. Schizophr. Bull. Epub ahead of print.
86. Tfelt-Hansen, P., & Tfelt-Hansen, J. (2009). Verapamil for cluster headache: Clinical pharmacology and possible mode of action. Headache 49, 117-125.
87. Tomppo, L., Hennah, W., Lahermo, P., Loukola, A., Tuulio-Henriksson, A., Suvisaari, J., Partonen, T., Ekelund, J., Lonnqvist, J., & Peltonen, L. (2009). Associa tion between genes of disrupted in schizophrenia 1 (DISC1) interactors and schizophrenia supports the role of the DISC1 pathway in the etiology of major mental illnesses. Biol. Psychiatry 65, 1055-1062.
88. Vitelli, F., Zhang, Z., Huynh, T., Sobotka, A., Mupo, A., & Baldini, A. (2006). Fgf8 expression in the Tbx1 domain causes skeletal abnormalities and modifi es the aortic arch but not the outfl ow tract phenotype of Tbx1 mutants. Dev. Biol. 295, 559-570.
89. Weiner, E. D., Kalasapudi, V. D., Papolos, D. F., & Lachman,H. M. (1991). Lithium augments pilocarpine-induced fos gene expression in rat brain. Brain Res. 553, 117-122.
90. Wellcome Trust Case Control Consortium. (2007). Genome-wide association study of 14,000 cases of seven common diseases and 3,000 shared controls. Nature 447, 661-678.
91. Xu, X., Bieda, M., Jin, V. X., Rabinovich, A., Oberley, M. J., Green, R., & Farnham, P. J. (2007). A comprehensive ChIP-chip analysis of E2F1, E2F4, and E2F6 in normal and tumor cells reveals interchangeable roles of E2F family members. Genome Res. 17, 1550-1561.
92. Yang, Y., Xiao, Z., Chen, W., Sang, H., Guan, Y., Peng, Y., Zhang, D., Gu, Z., Qian, M., He, G. et al. (2004). Tumor suppressor gene TP53 is genetically associated with schizophrenia in the chinese population. Neurosci. Lett. 369, 126-131.
93. Youngs, R. M., Chu, M. S., Meloni, E. G., Naydenov, A., Carlezon, W. A., Jr., & Konradi, C. (2006). Lithium administration to preadolescent rats causes long-lasting increases in anxiety-like behavior and has molecular consequences. J. Neurosci. 26, 6031-6039.
94. Zhang, W. V., Jullig, M., Connolly, A. R., & Stott, N. S. (2005). Early gene response in lithium chloride induced apoptosis. Apoptosis 10, 75-90.